BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 11342634)

  • 1. The exon A (C77G) mutation is a common cause of abnormal CD45 splicing in humans.
    Tchilian EZ; Wallace DL; Imami N; Liao HX; Burton C; Gotch F; Martinson J; Haynes BF; Beverley PC
    J Immunol; 2001 May; 166(10):6144-8. PubMed ID: 11342634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A point mutation in CD45 may be associated with an increased risk of HIV-1 infection.
    Tchilian EZ; Wallace DL; Dawes R; Imami N; Burton C; Gotch F; Beverley PC
    AIDS; 2001 Sep; 15(14):1892-4. PubMed ID: 11579257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prevalence of C77G polymorphism in exon 4 of the CD45 gene in the Spanish population].
    Gil J; Ruiz-Tíscar JL; Rodríguez-Sainz C; Hernández A; Santamaría B; García-Sánchez F; Fernández-Cruz E
    Med Clin (Barc); 2005 Jun; 125(1):10-1. PubMed ID: 15960938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A CD45 polymorphism associated with abnormal splicing is absent in African populations.
    Tchilian EZ; Dawes R; Ramaley PA; Whitworth JA; Yuldasheva N; Wells RS; Watera C; French N; Gilks CF; Kunachiwa W; Ruzibakiev R; Leetrakool N; Carrington CV; Ramdath DD; Gotch F; Stephens HA; Hill AV; Beverley PC
    Immunogenetics; 2002 Feb; 53(10-11):980-3. PubMed ID: 11862398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal cell surface antigen expression in individuals with variant CD45 splicing and histiocytosis.
    Boxall S; McCormick J; Beverley P; Strobel S; De Filippi P; Dawes R; Klersy C; Clementi R; De Juli E; Ferster A; Wallace D; Aricò M; Danesino C; Tchilian E
    Pediatr Res; 2004 Mar; 55(3):478-84. PubMed ID: 14630980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD45 and multiple sclerosis: the exon 4 C77G polymorphism (additional studies and meta-analysis) and new markers.
    Gomez-Lira M; Liguori M; Magnani C; Bonamini D; Salviati A; Leone M; Andreoli V; Trojano M; Valentino P; Savettieri G; Quattrone A; Pignatti PF; Momigliano-Richiardi P; Giordano M
    J Neuroimmunol; 2003 Jul; 140(1-2):216-21. PubMed ID: 12864992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A point mutation within CD45 exon A is the cause of variant CD45RA splicing in humans.
    Zilch CF; Walker AM; Timón M; Goff LK; Wallace DL; Beverley PC
    Eur J Immunol; 1998 Jan; 28(1):22-9. PubMed ID: 9485182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Linkage of the CCR5 Delta 32 mutation with a functional polymorphism of CD45RA.
    Liao HX; Montefiori DC; Patel DD; Lee DM; Scott WK; Pericak-Vance M; Haynes BF
    J Immunol; 2000 Jul; 165(1):148-57. PubMed ID: 10861047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered CD45 expression in C77G carriers influences immune function and outcome of hepatitis C infection.
    Dawes R; Hennig B; Irving W; Petrova S; Boxall S; Ward V; Wallace D; Macallan DC; Thursz M; Hill A; Bodmer W; Beverley PC; Tchilian EZ
    J Med Genet; 2006 Aug; 43(8):678-84. PubMed ID: 16505159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of alternative splicing of CD45 by antagonistic effects of SR protein splicing factors.
    ten Dam GB; Zilch CF; Wallace D; Wieringa B; Beverley PC; Poels LG; Screaton GR
    J Immunol; 2000 May; 164(10):5287-95. PubMed ID: 10799890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A disease-associated polymorphism alters splicing of the human CD45 phosphatase gene by disrupting combinatorial repression by heterogeneous nuclear ribonucleoproteins (hnRNPs).
    Motta-Mena LB; Smith SA; Mallory MJ; Jackson J; Wang J; Lynch KW
    J Biol Chem; 2011 Jun; 286(22):20043-53. PubMed ID: 21507955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alternative splicing of CD45: the tip of the iceberg.
    Zikherman J; Weiss A
    Immunity; 2008 Dec; 29(6):839-41. PubMed ID: 19100695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of amino acids at the junction of exons 3 and 7 that are used for the generation of glycosylation-related human CD45RO and CD45RO-like antigen specificities.
    Pulido R; Schlossman SF; Saito H; Streuli M
    J Exp Med; 1994 Mar; 179(3):1035-40. PubMed ID: 7509359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel CD45 transcript involving the alternative splicing of a new exon is widely distributed in lymphoid tissues.
    Li D; Brackenridge S; Screaton GR
    Hum Immunol; 2004 Dec; 65(12):1539-45. PubMed ID: 15603882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Normal B lymphocyte development but impaired T cell maturation in CD45-exon6 protein tyrosine phosphatase-deficient mice.
    Kishihara K; Penninger J; Wallace VA; Kündig TM; Kawai K; Wakeham A; Timms E; Pfeffer K; Ohashi PS; Thomas ML
    Cell; 1993 Jul; 74(1):143-56. PubMed ID: 8334701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel perforin mutation in a patient with hemophagocytic lymphohistiocytosis and CD45 abnormal splicing.
    McCormick J; Flower DR; Strobel S; Wallace DL; Beverley PC; Tchilian EZ
    Am J Med Genet A; 2003 Mar; 117A(3):255-60. PubMed ID: 12599189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HnRNP L and L-like cooperate in multiple-exon regulation of CD45 alternative splicing.
    Preussner M; Schreiner S; Hung LH; Porstner M; Jäck HM; Benes V; Rätsch G; Bindereif A
    Nucleic Acids Res; 2012 Jul; 40(12):5666-78. PubMed ID: 22402488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T cell development in mice expressing splice variants of the protein tyrosine phosphatase CD45.
    Kozieradzki I; Kündig T; Kishihara K; Ong CJ; Chiu D; Wallace VA; Kawai K; Timms E; Ionescu J; Ohashi P; Marth JD; Mak TW; Penninger JM
    J Immunol; 1997 Apr; 158(7):3130-9. PubMed ID: 9120266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SC35 plays a role in T cell development and alternative splicing of CD45.
    Wang HY; Xu X; Ding JH; Bermingham JR; Fu XD
    Mol Cell; 2001 Feb; 7(2):331-42. PubMed ID: 11239462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered CD45 isoform expression in C77G carriers influences cytokine responsiveness and adhesion properties of T cells.
    Windhagen A; Sönmez D; Hornig-Do HT; Kalinowsky A; Schwinzer R
    Clin Exp Immunol; 2007 Dec; 150(3):509-17. PubMed ID: 17903220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.